Receive our newsletter – data, insights and analysis delivered to you
  1. News
March 15, 2021

Metropolis introduces Covid-19 test to check immunity of vaccinated people

Diagnostics company Metropolis Healthcare has announced the launch of a blood test, COVIPROTECT, which helps to measure the immunity status of a person vaccinated with the Covid-19 vaccine.

Diagnostics company Metropolis Healthcare has announced the launch of a blood test, COVIPROTECT, which helps to measure the immunity status of a person vaccinated with the Covid-19 vaccine.

The new and upgraded quantitative test helps to understand seroprevalence in a community and determine the possibility of past infection.

The highly sensitive and specific antibody assay detects IgG type of antibodies to S1 & S2 subunits of spike proteins of SARS-CoV-2.

COVIPROTECT is Conformité Européenne (CE) marked and is approved by the US Food and Drug Administration (FDA) EUA as reported by HEALTHCARERADIUS.

Metropolis Healthcare Group president Nilesh Shah said: “Metropolis has been at the forefront of Covid-19 testing across the country from day one of the pandemic. In our pursuit to offer the best possible tests for the citizens, we have launched this immunity-check test called COVIPROTECT.

“This test is not mandatory but helps people understand if they have responded to the vaccine and if they have developed enough antibodies.”

Content from our partners
The added value of Qarad’s multilingual freephone service to their eIFU solution
Small and simple: how medical device manufacturers select materials
Precision wire: The future of bespoke medical treatment

The test is available across the company’s network in India. It determines the antibodies against the viral spike proteins and if a person has developed enough antibodies after vaccination.

It is recommended to take the test three to four weeks after natural infection and two weeks after the second dose of the vaccine.

Reports will be generated within 24 hours.

Metropolis is currently assisting patients and vaccinated individuals to study their antibody titre.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU